$8.13 Billion is the total value of Orbimed Advisors's 140 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 43.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ICPT | INTERCEPT PHARMACEUTICALS IN | $572,164,000 | +383.0% | 1,734,934 | 0.0% | 7.04% | +304.1% | |
| GILD | Buy | GILEAD SCIENCES INC | $376,607,000 | +0.4% | 5,314,800 | +6.5% | 4.63% | -16.0% |
| BIIB | Sell | BIOGEN IDEC INC | $324,436,000 | +6.0% | 1,060,700 | -3.1% | 3.99% | -11.3% |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $309,954,000 | +6.7% | 5,966,400 | +9.2% | 3.81% | -10.7% |
| RLYP | Buy | RELYPSA INC | $296,358,000 | +19.2% | 9,941,551 | +0.0% | 3.64% | -0.2% |
| AMGN | Sell | AMGEN INC | $285,643,000 | -0.5% | 2,315,900 | -7.9% | 3.51% | -16.7% |
| AGN | Buy | ALLERGAN INC | $281,707,000 | +227.2% | 2,270,000 | +192.8% | 3.46% | +173.8% |
| ABBV | Buy | ABBVIE INC | $246,401,000 | +24.1% | 4,793,800 | +27.5% | 3.03% | +3.8% |
| HCA | Buy | HCA HOLDINGS INC | $221,288,000 | +23.4% | 4,215,000 | +12.2% | 2.72% | +3.3% |
| ILMN | Sell | ILLUMINA INC | $202,252,000 | +14.5% | 1,360,500 | -14.8% | 2.49% | -4.2% |
| ITMN | Sell | INTERMUNE INC | $199,213,000 | +75.7% | 5,952,000 | -22.7% | 2.45% | +47.1% |
| CELG | Sell | CELGENE CORP | $191,447,000 | -35.5% | 1,371,400 | -22.0% | 2.35% | -46.0% |
| MYL | Sell | MYLAN INC | $190,706,000 | +4.3% | 3,905,500 | -7.3% | 2.34% | -12.8% |
| MDVN | Sell | MEDIVATION INC | $175,350,000 | -12.0% | 2,724,100 | -12.8% | 2.16% | -26.4% |
| A | Buy | AGILENT TECHNOLOGIES INC | $170,142,000 | -1.4% | 3,042,600 | +0.8% | 2.09% | -17.5% |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $167,518,000 | -1.9% | 1,393,200 | -9.2% | 2.06% | -18.0% |
| INCY | Sell | INCYTE CORP | $167,196,000 | -18.8% | 3,124,000 | -23.2% | 2.06% | -32.1% |
| PRGO | New | PERRIGO CO PLC | $163,445,000 | – | 1,056,800 | +100.0% | 2.01% | – |
| REGN | Sell | REGENERON PHARMACEUTICALS | $161,851,000 | -20.4% | 539,000 | -27.0% | 1.99% | -33.4% |
| ESRX | Buy | EXPRESS SCRIPTS HLDG CO | $157,464,000 | +74.2% | 2,097,000 | +62.9% | 1.94% | +45.7% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $147,296,000 | +414.8% | 336,300 | +351.4% | 1.81% | +330.2% |
| MRK | MERCK & CO INC NEW | $144,593,000 | +13.4% | 2,547,000 | 0.0% | 1.78% | -5.1% | |
| IPXL | Buy | IMPAX LABORATORIES INC | $141,231,000 | +32.6% | 5,345,600 | +26.1% | 1.74% | +10.9% |
| PFE | Buy | PFIZER INC | $117,591,000 | +8.1% | 3,661,000 | +3.0% | 1.45% | -9.6% |
| MCK | Buy | MCKESSON CORP | $102,234,000 | +78.4% | 579,000 | +63.1% | 1.26% | +49.3% |
| B108PS | Sell | ACTAVIS PLC | $101,896,000 | -14.9% | 495,000 | -30.6% | 1.25% | -28.8% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $101,838,000 | +2.4% | 1,493,000 | +5.6% | 1.25% | -14.4% |
| PODD | Sell | INSULET CORP | $91,687,000 | -14.4% | 1,933,500 | -33.1% | 1.13% | -28.4% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $87,761,000 | +257.1% | 5,451,000 | +107.2% | 1.08% | +198.9% |
| SHPG | Sell | SHIRE PLCsponsored adr | $87,187,000 | -14.8% | 587,000 | -18.9% | 1.07% | -28.7% |
| HNT | Buy | HEALTH NET INC | $87,066,000 | +87.9% | 2,560,000 | +64.0% | 1.07% | +57.3% |
| MOH | Buy | MOLINA HEALTHCARE INC | $84,623,000 | +18.0% | 2,253,000 | +9.2% | 1.04% | -1.2% |
| CFN | Sell | CAREFUSION CORP | $80,923,000 | -6.4% | 2,012,000 | -7.3% | 1.00% | -21.7% |
| STJ | Buy | ST JUDE MED INC | $74,976,000 | +45.2% | 1,146,600 | +37.5% | 0.92% | +21.5% |
| SPY | Buy | SPDR S&P 500 ETF TRput | $74,804,000 | +20117.3% | 400,000 | +60.0% | 0.92% | +18300.0% |
| PRTA | Buy | PROTHENA CORP PLC | $72,368,000 | +127.0% | 1,889,000 | +57.2% | 0.89% | +90.2% |
| ZBH | Sell | ZIMMER HLDGS INC | $67,738,000 | -13.0% | 716,200 | -14.2% | 0.83% | -27.2% |
| XLRN | Sell | ACCELERON PHARMA INC | $64,439,000 | -23.2% | 1,867,800 | -11.8% | 0.79% | -35.7% |
| ARWR | Buy | ARROWHEAD RESH CORP | $64,202,000 | +177.9% | 3,910,000 | +83.7% | 0.79% | +133.0% |
| FLDM | Buy | FLUIDIGM CORP DEL | $63,778,000 | +15.2% | 1,447,200 | +0.1% | 0.78% | -3.7% |
| JNJ | Sell | JOHNSON & JOHNSON | $58,643,000 | +2.3% | 597,000 | -4.6% | 0.72% | -14.5% |
| INFI | Sell | INFINITY PHARMACEUTICALS INC | $56,322,000 | -14.9% | 4,736,900 | -1.2% | 0.69% | -28.8% |
| SYK | Sell | STRYKER CORP | $51,057,000 | -5.2% | 626,700 | -12.6% | 0.63% | -20.6% |
| AFFX | Sell | AFFYMETRIX INC | $47,721,000 | -18.2% | 6,693,000 | -1.7% | 0.59% | -31.6% |
| OSUR | Buy | ORASURE TECHNOLOGIES INC | $42,815,000 | +36.5% | 5,372,000 | +7.7% | 0.53% | +14.3% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $41,482,000 | +30.7% | 2,347,600 | +79.1% | 0.51% | +9.4% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $40,619,000 | +31.2% | 267,000 | +14.6% | 0.50% | +9.9% |
| BMY | Buy | BRISTOL MYERS SQUIBB COcall | $38,963,000 | +33.3% | 750,000 | +36.4% | 0.48% | +11.4% |
| LLY | New | LILLY ELI & CO | $31,961,000 | – | 543,000 | +100.0% | 0.39% | – |
| TRNX | New | TORNIER N V | $31,302,000 | – | 1,475,100 | +100.0% | 0.38% | – |
| ARRY | Buy | ARRAY BIOPHARMA INC | $29,596,000 | +10.9% | 6,297,000 | +18.3% | 0.36% | -7.1% |
| XNPT | Buy | XENOPORT INC | $28,673,000 | +8.6% | 5,546,100 | +20.8% | 0.35% | -9.0% |
| NXTM | Sell | NXSTAGE MEDICAL INC | $26,920,000 | +0.5% | 2,113,000 | -21.1% | 0.33% | -16.0% |
| EXAS | Sell | EXACT SCIENCES CORP | $26,824,000 | -54.2% | 1,893,000 | -62.1% | 0.33% | -61.7% |
| Sell | INCYTE CORPnote 4.750%10/0 | $24,975,000 | -12.2% | 4,242,000 | -15.0% | 0.31% | -26.6% | |
| TSRO | New | TESARO INC | $24,993,000 | – | 847,800 | +100.0% | 0.31% | – |
| AGN | New | ALLERGAN INCcall | $24,820,000 | – | 200,000 | +100.0% | 0.30% | – |
| PTLA | PORTOLA PHARMACEUTICALS INC | $24,804,000 | +0.6% | 957,700 | 0.0% | 0.30% | -15.7% | |
| MRTX | MIRATI THERAPEUTICS INC | $24,302,000 | +14.7% | 1,274,332 | 0.0% | 0.30% | -3.9% | |
| DRTX | DURATA THERAPEUTICS INC | $24,046,000 | +5.3% | 1,785,714 | 0.0% | 0.30% | -11.9% | |
| IBB | New | ISHARESput | $23,640,000 | – | 100,000 | +100.0% | 0.29% | – |
| PTCT | New | PTC THERAPEUTICS INC | $21,699,000 | – | 830,100 | +100.0% | 0.27% | – |
| MEIP | Sell | MEI PHARMA INC | $21,420,000 | +34.4% | 1,924,500 | -3.3% | 0.26% | +12.4% |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $21,142,000 | – | 1,075,400 | +100.0% | 0.26% | – |
| CERS | Buy | CERUS CORP | $20,342,000 | -6.6% | 4,238,000 | +25.6% | 0.25% | -21.9% |
| MDT | MEDTRONIC INC | $19,877,000 | +7.2% | 323,000 | 0.0% | 0.24% | -10.3% | |
| New | FLUIDIGM CORP DELnote 2.750% 2/0 | $19,395,000 | – | 17,000,000 | +100.0% | 0.24% | – | |
| CAH | Buy | CARDINAL HEALTH INC | $18,685,000 | +21.4% | 267,000 | +15.9% | 0.23% | +1.8% |
| VRX | Sell | VALEANT PHARMACEUTICALS INTL | $17,533,000 | -4.9% | 133,000 | -15.3% | 0.22% | -20.3% |
| AGEN | New | AGENUS INC | $16,009,000 | – | 5,050,000 | +100.0% | 0.20% | – |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $15,948,000 | +9.6% | 115,000 | 0.0% | 0.20% | -8.4% | |
| New | VOLCANO CORPORATIONnote 1.750%12/0 | $14,887,000 | – | 15,000,000 | +100.0% | 0.18% | – | |
| MGNX | MACROGENICS INC | $13,689,000 | +1.5% | 491,897 | 0.0% | 0.17% | -15.2% | |
| AMBI | AMBIT BIOSCIENCES CORP | $13,596,000 | -5.4% | 1,490,769 | 0.0% | 0.17% | -20.9% | |
| IRWD | New | IRONWOOD PHARMACEUTICALS INC | $13,331,000 | – | 1,082,100 | +100.0% | 0.16% | – |
| INO | New | INOVIO PHARMACEUTICALS INC | $13,277,000 | – | 3,987,000 | +100.0% | 0.16% | – |
| AZN | New | ASTRAZENECA PLCcall | $12,976,000 | – | 200,000 | +100.0% | 0.16% | – |
| ABBV | ABBVIE INCcall | $12,850,000 | -2.7% | 250,000 | 0.0% | 0.16% | -18.6% | |
| XOMA | Sell | XOMA CORP DEL | $12,697,000 | -33.3% | 2,437,000 | -13.9% | 0.16% | -44.3% |
| NUVA | New | NUVASIVE INC | $12,138,000 | – | 316,000 | +100.0% | 0.15% | – |
| ALIM | New | ALIMERA SCIENCES INC | $11,835,000 | – | 1,500,000 | +100.0% | 0.15% | – |
| PTX | Sell | PERNIX THERAPEUTICS HLDGS IN | $11,762,000 | +101.1% | 2,198,500 | -5.3% | 0.14% | +68.6% |
| SVA | SINOVAC BIOTECH LTD | $11,790,000 | +17.6% | 1,637,500 | 0.0% | 0.14% | -1.4% | |
| ARQL | ARQULE INC | $11,689,000 | -4.6% | 5,702,000 | 0.0% | 0.14% | -20.0% | |
| FLDM | New | FLUIDIGM CORP DELcall | $11,409,000 | – | 100,000 | +100.0% | 0.14% | – |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $11,315,000 | -40.3% | 160,000 | -37.3% | 0.14% | -50.0% |
| MRGE | MERGE HEALTHCARE INC | $11,294,000 | +5.2% | 4,628,500 | 0.0% | 0.14% | -12.0% | |
| ATRS | Sell | ANTARES PHARMA INC | $11,249,000 | -45.2% | 3,213,900 | -30.0% | 0.14% | -54.3% |
| NSPR | INSPIREMD INC | $10,355,000 | +24.0% | 3,395,000 | 0.0% | 0.13% | +3.3% | |
| EXEL | Sell | EXELIXIS INC | $10,224,000 | -82.2% | 2,888,000 | -69.2% | 0.13% | -85.1% |
| CFN | New | CAREFUSION CORPcall | $10,055,000 | – | 250,000 | +100.0% | 0.12% | – |
| DVA | DAVITA HEALTHCARE PARTNERS I | $9,846,000 | +8.7% | 143,000 | 0.0% | 0.12% | -9.0% | |
| MYL | New | MYLAN INCcall | $9,766,000 | – | 200,000 | +100.0% | 0.12% | – |
| XNCR | Buy | XENCOR INC | $9,404,000 | +46.4% | 801,700 | +14.1% | 0.12% | +23.4% |
| AEGR | New | AEGERION PHARMACEUTICALS INCcall | $9,236,000 | – | 200,000 | +100.0% | 0.11% | – |
| AEGR | New | AEGERION PHARMACEUTICALS INCput | $9,236,000 | – | 200,000 | +100.0% | 0.11% | – |
| GEVA | Sell | SYNAGEVA BIOPHARMA CORP | $9,218,000 | +9.6% | 111,100 | -14.5% | 0.11% | -8.9% |
| RDHL | New | REDHILL BIOPHARMA LTDsponsored ads | $8,899,000 | – | 631,580 | +100.0% | 0.11% | – |
| FRX | Sell | FOREST LABS INC | $8,673,000 | +3.9% | 94,000 | -32.4% | 0.11% | -13.0% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $8,363,000 | -86.0% | 102,000 | -87.1% | 0.10% | -88.2% |
| SNSS | New | SUNESIS PHARMACEUTICALS INC | $7,932,000 | – | 1,200,000 | +100.0% | 0.10% | – |
| PRGO | New | PERRIGO CO PLCcall | $7,733,000 | – | 50,000 | +100.0% | 0.10% | – |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $7,514,000 | -38.8% | 462,400 | -53.3% | 0.09% | -49.2% |
| VCRA | VOCERA COMMUNICATIONS INC | $7,308,000 | +4.6% | 447,500 | 0.0% | 0.09% | -12.6% | |
| VRTX | New | VERTEX PHARMACEUTICALS INCput | $6,867,000 | – | 97,100 | +100.0% | 0.08% | – |
| FATE | Sell | FATE THERAPEUTICS INC | $6,749,000 | +53.1% | 692,900 | -1.3% | 0.08% | +27.7% |
| ABT | Sell | ABBOTT LABS | $6,701,000 | -42.7% | 174,000 | -43.0% | 0.08% | -52.3% |
| CVD | Buy | COVANCE INC | $6,546,000 | +26.0% | 63,000 | +6.8% | 0.08% | +6.6% |
| BLUE | New | BLUEBIRD BIO INC | $6,572,000 | – | 289,000 | +100.0% | 0.08% | – |
| CBST | CUBIST PHARMACEUTICALS INC | $6,584,000 | +6.2% | 90,000 | 0.0% | 0.08% | -11.0% | |
| ZTS | Sell | ZOETIS INCcl a | $6,396,000 | -29.9% | 221,000 | -20.8% | 0.08% | -41.0% |
| RPTP | New | RAPTOR PHARMACEUTICAL CORP | $6,000,000 | – | 600,000 | +100.0% | 0.07% | – |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $5,670,000 | -57.4% | 95,500 | -70.2% | 0.07% | -64.1% |
| CRIS | CURIS INC | $5,499,000 | 0.0% | 1,950,100 | 0.0% | 0.07% | -16.0% | |
| GILD | New | GILEAD SCIENCES INCput | $5,315,000 | – | 75,000 | +100.0% | 0.06% | – |
| QCOR | QUESTCOR PHARMACEUTICALS INC | $5,194,000 | +19.2% | 80,000 | 0.0% | 0.06% | 0.0% | |
| SUPN | SUPERNUS PHARMACEUTICALS INC | $5,185,000 | +18.6% | 580,000 | 0.0% | 0.06% | 0.0% | |
| UPI | Sell | UROPLASTY INC | $4,950,000 | +25.6% | 1,363,500 | -5.5% | 0.06% | +5.2% |
| MDXG | Buy | MIMEDX GROUP INC | $4,876,000 | -20.3% | 795,400 | +13.6% | 0.06% | -33.3% |
| AET | Sell | AETNA INC NEW | $4,723,000 | -94.1% | 63,000 | -94.6% | 0.06% | -95.1% |
| CPRX | CATALYST PHARM PARTNERS INC | $4,283,000 | +15.9% | 1,895,000 | 0.0% | 0.05% | -1.9% | |
| BONE | Buy | BACTERIN INTL HLDGS INC | $3,994,000 | +145.5% | 4,754,386 | +46.1% | 0.05% | +104.2% |
| DSCI | New | DERMA SCIENCES INC | $3,804,000 | – | 300,000 | +100.0% | 0.05% | – |
| IRWD | New | IRONWOOD PHARMACEUTICALS INCcall | $3,696,000 | – | 300,000 | +100.0% | 0.04% | – |
| BSX | New | BOSTON SCIENTIFIC CORP | $3,673,000 | – | 271,700 | +100.0% | 0.04% | – |
| QCOR | Sell | QUESTCOR PHARMACEUTICALS INCcall | $3,247,000 | -29.8% | 50,000 | -41.2% | 0.04% | -41.2% |
| ANGO | New | ANGIODYNAMICS INCcall | $3,150,000 | – | 200,000 | +100.0% | 0.04% | – |
| ANTH | ANTHERA PHARMACEUTICALS INC | $3,125,000 | +9.1% | 932,750 | 0.0% | 0.04% | -9.5% | |
| HZNP | New | HORIZON PHARMA INC | $2,964,000 | – | 196,000 | +100.0% | 0.04% | – |
| BLRX | BIOLINERX LTDsponsored adr | $2,531,000 | -20.6% | 1,135,000 | 0.0% | 0.03% | -34.0% | |
| CERS | New | CERUS CORPcall | $2,400,000 | – | 500,000 | +100.0% | 0.03% | – |
| QLTI | Sell | QLT INC | $1,668,000 | -33.5% | 300,000 | -33.3% | 0.02% | -43.2% |
| MNKD | New | MANNKIND CORPput | $1,608,000 | – | 400,000 | +100.0% | 0.02% | – |
| EXAS | Buy | EXACT SCIENCES CORPput | $1,417,000 | +39.9% | 100,000 | +16.0% | 0.02% | +13.3% |
| BIOD | Sell | BIODEL INC | $1,092,000 | -12.5% | 400,000 | -26.9% | 0.01% | -27.8% |
| ENDOLOGIX INCnote 2.250%12/1 | $964,000 | -5.1% | 1,000,000 | 0.0% | 0.01% | -20.0% | ||
| ZGNX | New | ZOGENIX INCcall | $875,000 | – | 307,600 | +100.0% | 0.01% | – |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $724,000 | -38.7% | 400,000 | -33.3% | 0.01% | -47.1% |
| BIOMARIN PHARMACEUTICAL INCnote 0.750%10/1 | $546,000 | +1.7% | 500,000 | 0.0% | 0.01% | -12.5% | ||
| BIOMARIN PHARMACEUTICAL INCnote 1.500%10/1 | $553,000 | +2.8% | 500,000 | 0.0% | 0.01% | -12.5% | ||
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDput | $0 | – | -200,000 | -100.0% | -0.00% | – |
| CHDX | Exit | CHINDEX INTERNATIONAL INC | $0 | – | -36,000 | -100.0% | -0.01% | – |
| OPHT | Exit | OPHTHOTECH CORP | $0 | – | -34,500 | -100.0% | -0.02% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -135,000 | -100.0% | -0.05% | – |
| HSP | Exit | HOSPIRA INC | $0 | – | -85,000 | -100.0% | -0.05% | – |
| INCY | Exit | INCYTE CORPcall | $0 | – | -70,000 | -100.0% | -0.05% | – |
| TECH | Exit | TECHNE CORP | $0 | – | -50,000 | -100.0% | -0.07% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -55,000 | -100.0% | -0.09% | – |
| Exit | OREXIGEN THERAPEUTICS INCnote 2.750%12/0 | $0 | – | -7,500,000 | -100.0% | -0.11% | – | |
| FRX | Exit | FOREST LABS INCcall | $0 | – | -150,000 | -100.0% | -0.13% | – |
| ILMN | Exit | ILLUMINA INCcall | $0 | – | -100,000 | -100.0% | -0.16% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -244,000 | -100.0% | -0.25% | – |
| PRGO | Exit | PERRIGO COcall | $0 | – | -175,000 | -100.0% | -0.40% | – |
| V107SC | Exit | WELLPOINT INC | $0 | – | -429,000 | -100.0% | -0.58% | – |
| QGEN | Exit | QIAGEN NV | $0 | – | -1,927,000 | -100.0% | -0.67% | – |
| PRGO | Exit | PERRIGO CO | $0 | – | -773,000 | -100.0% | -1.74% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-15
About Orbimed Advisors
Orbimed Advisors is a leading healthcare-focused investment firm that manages over $16 billion in assets. The firm was founded in 1998 by Samuel Isaly, who has over 50 years of experience in the healthcare industry. Isaly is widely regarded as a pioneer in the field of healthcare investing and has been recognized for his contributions to the industry by numerous organizations.
Orbimed Advisors has a team of over 100 professionals, including investment professionals, research analysts, and operational experts. The firm has offices in New York, San Francisco, Shanghai, and Mumbai, and invests in companies across the healthcare spectrum, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
The firm's investment philosophy is based on a deep understanding of the healthcare industry and a rigorous approach to due diligence. Orbimed Advisors seeks to identify companies with innovative technologies and strong management teams that have the potential to transform the healthcare landscape.
Orbimed Advisors has a strong track record of success, with numerous successful investments in companies such as Juno Therapeutics, Spark Therapeutics, and Kite Pharma. The firm's leadership team, which includes CEO Sven Borho, COO Jonathan Silverstein, and Chief Investment Officer Carl Gordon, has decades of experience in the healthcare industry and is widely respected for their expertise and insights.
Overall, Orbimed Advisors is a leading healthcare investment firm that has a proven track record of success and a deep understanding of the healthcare industry. Investors looking to gain exposure to the healthcare sector may want to consider Orbimed Advisors as a potential investment opportunity.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 42 | Q3 2023 | 5.0% |
| VERTEX PHARMACEUTICALS INC | 42 | Q3 2023 | 3.7% |
| THERMO FISHER SCIENTIFIC INC | 42 | Q3 2023 | 3.2% |
| SINOVAC BIOTECH LTD | 41 | Q3 2023 | 7.2% |
| NEUROCRINE BIOSCIENCES INC | 41 | Q3 2023 | 2.7% |
| BOSTON SCIENTIFIC CORP | 40 | Q3 2023 | 5.6% |
| BRISTOL-MYERS SQUIBB CO | 40 | Q2 2023 | 5.2% |
| AMGEN INC | 40 | Q3 2023 | 5.5% |
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.8% |
| GILEAD SCIENCES INC | 39 | Q3 2023 | 5.5% |
View Orbimed Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ikena Oncology, Inc. | September 21, 2023 | 2,189,111 | 5.2% |
| Galecto, Inc. | September 18, 2023 | 749,557 | 2.8% |
| PMV Pharmaceuticals, Inc. | August 23, 2023 | 6,563,077 | 13.5% |
| Gracell Biotechnologies Inc. | August 11, 2023 | 7,641,531 | 8.0% |
| Xtant Medical Holdings, Inc. | August 03, 2023 | 73,114,592 | 56.7% |
| Turnstone Biologics Corp. | July 24, 2023 | 3,099,265 | 13.4% |
| Prelude Therapeutics Inc | May 24, 2023 | 15,716,642 | 28.6% |
| VectivBio Holding AG | May 24, 2023 | 5,156,561 | 7.7% |
| Fusion Pharmaceuticals Inc. | May 16, 2023 | 2,930,670 | 4.6% |
| Verona Pharma plc | May 16, 2023 | 3,777,778 | 4.8% |
View Orbimed Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-26 |
| 4 | 2024-04-23 |
| 4 | 2024-04-18 |
| 4 | 2024-04-15 |
| 3/A | 2024-04-12 |
| SC 13D/A | 2024-04-12 |
| 4 | 2024-04-05 |
| SC 13D/A | 2024-04-04 |
| 3 | 2024-04-03 |
| SC 13D | 2024-03-28 |
View Orbimed Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.